Cumberland Partners Ltd Cuts Stock Holdings in HCA Healthcare, Inc. $HCA

Cumberland Partners Ltd reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 63.6% in the first quarter, Holdings Channel.com reports. The fund owned 3,000 shares of the company’s stock after selling 5,250 shares during the period. Cumberland Partners Ltd’s holdings in HCA Healthcare were worth $1,420,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Norges Bank purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at about $374,037,000. Viking Global Investors LP raised its holdings in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after purchasing an additional 649,058 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its stake in HCA Healthcare by 5,941.1% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 381,433 shares of the company’s stock valued at $180,509,000 after buying an additional 375,119 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of HCA stock opened at $382.28 on Friday. The company has a market capitalization of $84.80 billion, a price-to-earnings ratio of 13.15, a PEG ratio of 1.27 and a beta of 1.12. The company’s fifty day moving average price is $386.95 and its 200-day moving average price is $453.73. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.During the same period last year, the firm earned $6.84 earnings per share. The business’s quarterly revenue was up 8.7% on a year-over-year basis. Equities research analysts expect that HCA Healthcare, Inc. will post 29.19 earnings per share for the current fiscal year.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

Analyst Ratings Changes

Several analysts recently commented on the company. Barclays cut their price objective on HCA Healthcare from $427.00 to $402.00 and set an “equal weight” rating for the company in a report on Thursday, July 16th. Stephens cut their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Finally, Robert W. Baird cut their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $483.45.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.